| Alan S Tesler, MD | |
|
16233 Sylvester Road Sw, Suite 120, C/o Swedish Cancer Institute @ Highline, Burien, WA 98166 | |
| (206) 386-2626 | |
| (206) 246-7344 |
| Full Name | Alan S Tesler |
|---|---|
| Gender | Male |
| Speciality | Radiology - Radiation Oncology |
| Location | 16233 Sylvester Road Sw, Suite 120, Burien, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629092705 | NPI | - | NPPES |
| 1005115 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | MD00022222 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alan S Tesler, MD Po Box 3713, Seattle, WA 98124-3713 Ph: (206) 749-5130 | Alan S Tesler, MD 16233 Sylvester Road Sw, Suite 120, C/o Swedish Cancer Institute @ Highline, Burien, WA 98166 Ph: (206) 386-2626 |
News Archive
Celsion Corporation, a leading oncology drug development company, announced today financial results for the first quarter ended March 31, 2010 and addressed the progression of the clinical trials of ThermoDox®, Celsion's heat activated liposomal encapsulation of doxorubicin. ThermoDox® is currently being evaluated in the Phase III HEAT trial for the treatment of hepatocellular carcinoma (HCC) and in a Phase I/II trial for patients with recurrent chest wall breast cancer.
Nina Navajas Pertegás, assistant professor and researcher at the UV Department of Social Work and Social Services, has carried out a study on the consequences of fatphobia and the cultural imposition of thinness through her own experience, with a body itinerary that ranges from her childhood to adulthood.
One of the most effective measures for containing the transmission of a virus is to identify who an infected person has been in contact and/or crossed paths with, mainly during incubation periods.
Chagas disease, a deadly tropical infection caused by the protozoan parasite Trypanosoma cruzi and transmitted by biting insects called "kissing bugs," has begun to spread around the world, including the U.S. Yet current treatment is toxic and limited to the acute stage.
A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.
› Verified 6 days ago
Dr. Rachel Faye Gerson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 16251 Sylvester Rd Sw, Burien, WA 98166 Phone: 206-248-8900 |